Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

The treatment was ineffective in humans.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

CD2 might be a new treatment target for patchy alopecia areata.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

The combination treatment showed a higher response rate but no significant survival benefits.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.